GENOMIC AND FUNCTIONAL CHARACTERIZATION OF ONCOGENIC BMX IN PROSTATE CANCER

$124,200FY2008Department of the ArmyDOD

Dana-Farber Cancer Institute, Inc.

Investigators

View source on USAspending →